Cargando…

Multiple Myeloma and the Kidney

Detalles Bibliográficos
Autores principales:	Cancarini, Giovanni, Terlizzi, Vincenzo, Zeni, Letizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055302/ https://www.ncbi.nlm.nih.gov/pubmed/33889810 http://dx.doi.org/10.1097/HS9.0000000000000556

Ejemplares similares

Acute Kidney Injury due to Anticoagulant-Related Nephropathy : A Suggestion for Therapy
por: Zeni, Letizia, et al.
Publicado: (2020)

Ten-year experience of an outpatient clinic for CKD-5 patients with multidisciplinary team and educational support
por: Terlizzi, Vincenzo, et al.
Publicado: (2021)

A more tubulocentric view of diabetic kidney disease
por: Zeni, Letizia, et al.
Publicado: (2017)

Induction Treatment in Transplant-eligible Multiple Myeloma
por: Quinn, J., et al.
Publicado: (2021)

Management of patients with multiple myeloma during the COVID-19 pandemic
por: Malard, Florent, et al.
Publicado: (2020)

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
por: Bird, Sarah, et al.
Publicado: (2021)

Multiple myeloma and infection: this association is still close
por: Garnica, Marcia
Publicado: (2019)

Visualizing the Heterogeneity of Effects in the Analysis of Associations of Multiple Myeloma with Glyphosate Use. Comments on Sorahan, T. Multiple Myeloma and Glyphosate Use: A Re-Analysis of US Agricultural Health Study (AHS) Data. Int. J. Environ. Res. Public Health 2015, 12, 1548–1559
por: Burstyn, Igor, et al.
Publicado: (2016)

Comment on “Outcomes of autologous transplantation for multiple myeloma according to different induction regimens”
por: de la Rubia, Javier
Publicado: (2014)

Comment on: “Validation of interphase fluorescence in situ hybridization (iFISH) of CD138 positive cells in multiple myeloma”()
por: Zalcberg Renault, Ilana
Publicado: (2016)

Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity
por: Wang, Yingying, et al.
Publicado: (2018)

Exploration of a panel of urine biomarkers of kidney disease in two paediatric cohorts with Type 1 diabetes mellitus of differing duration
por: Zeni, Letizia, et al.
Publicado: (2022)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

Save the kidneys in COVID-19
por: Knight, Philip P., et al.
Publicado: (2020)

eHealth in kidney care
por: Wang, Chia-shi, et al.
Publicado: (2020)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
por: Fusco, Vittorio, et al.
Publicado: (2018)

Radioactivity to Rethink the Earth's Energy Balance
por: Terranova, Maria Letizia
Publicado: (2021)

Multiple comparisons
por: Saxon, Emma
Publicado: (2015)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Cell death in ectopic calcification of the kidney
por: Priante, Giovanna, et al.
Publicado: (2019)

Kidney health in the context of economic development
por: Morton, Rachael L., et al.
Publicado: (2020)

The impact of COVID-19 on kidney transplantation
por: Alasfar, Sami, et al.
Publicado: (2020)

Detecting chronic kidney disease by electrocardiography
por: Kooman, Jeroen P.
Publicado: (2023)

Consequences of famine and malnourishment on kidney health
por: Navis, Gerjan
Publicado: (2023)

Multiple Myeloma and Kidney Disease
por: Katagiri, Daisuke, et al.
Publicado: (2013)

Reply to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology
por: Raje, Noopur, et al.
Publicado: (2019)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

Educating primary healthcare providers about kidney disease
por: Bello, Aminu K., et al.
Publicado: (2021)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Kidney involvement in COVID-19 and rationale for extracorporeal therapies
por: Ronco, Claudio, et al.
Publicado: (2020)

Electronic patient-reported outcomes in chronic kidney disease
por: Anderson, Nicola, et al.
Publicado: (2022)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
por: Vart, Priya, et al.
Publicado: (2022)

Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
por: Vigorito, Afonso Celso
Publicado: (2016)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Kidney disease in Venezuela: the impact of a lingering humanitarian crisis
por: Bellorin-Font, Ezequiel, et al.
Publicado: (2021)

Multiple levels of the unknown in microbiome research
por: Thomas, Andrew Maltez, et al.
Publicado: (2019)

Sustainable social development: tackling poverty to achieve kidney health equity
por: Moosa, M. R., et al.
Publicado: (2020)

Brazilian public policy for chronic kidney disease prevention: challenges and perspectives
por: Silva, Patrícia Aparecida Barbosa, et al.
Publicado: (2020)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
por: Schnell, Oliver, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hkh0femav65gqm0kc4jcdi5pnd